Xarelto 20 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QS1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,262
Award facts
- Contract value 100% obligated
- $46,262.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $46,262.03 by the Defense Logistics Agency on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract calls for the delivery of Xarelto 20 mg tablets in quantities of 90 to the Conshohocken, PA facility. This award was not set aside and represents a competitive procurement. The delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
Xarelto is a brand-name anticoagulant medication used in military and veteran healthcare systems for various thrombotic conditions. This delivery order exemplifies the routine pharmaceutical procurement activities conducted through the DLA's comprehensive contract vehicle with Cencora, Inc., which enables the efficient fulfillment of critical medication needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The firm fixed-price structure and rapid completion timeline reflect the nature of routine pharmaceutical supply orders within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F5QS1?
SPE2DR26F5QS1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F5QS1 worth?
The government has obligated $46,262 on SPE2DR26F5QS1.
Is contract SPE2DR26F5QS1 an order under another contract?
Yes. SPE2DR26F5QS1 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.
Was contract SPE2DR26F5QS1 competed?
The extent of competition for SPE2DR26F5QS1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award